NAD+ and NMN are sold as supplements and, in clinics, as compounded preparations. The human evidence that either slows aging is limited. Read the biology before you read the price tag.
Picture a small factory line running inside every cell in the body. Raw material comes in one end, a molecule gets built, and that finished molecule gets handed off to machinery that keeps the cell running and repairing itself. That is roughly what happens with NAD+. NMN is the raw material. NAD+ is the finished product. The machinery on the receiving end, enzymes called sirtuins and PARPs, uses NAD+ as a required cofactor for jobs tied to energy metabolism and DNA repair [4]. The pitch behind every NAD+ and NMN product on the market is that if the factory line slows down with age, restocking the raw material should help. Whether that pitch survives contact with the actual trial data is the real story here, and it is worth walking through the biology before anyone reaches for a wallet.
Step one: the decline is measured, not marketed
Start with the part that holds up. NAD+ really does drop as people age. A 2012 study measured NAD+ directly in human skin tissue across ages from newborn to 77 and found a strong negative correlation between NAD+ levels and age, in both men and women [5]. That is a hard finding, not an inference. The premise underneath this whole category, less NAD+ as you get older, is measured fact.
What that finding cannot tell you is whether refilling the tank changes anything a person would notice. That gap between a measured decline and a meaningful benefit is where this story gets interesting, and it is where the marketing tends to stop asking questions.
Step two: the precursor does raise the marker
If someone takes NMN, or its close relative nicotinamide riboside, their NAD+ markers go up. That part of the mechanism checks out in controlled human research, not just cell culture. A 2018 placebo-controlled crossover trial found that chronic nicotinamide riboside supplementation was well tolerated and effectively stimulated NAD+ metabolism in healthy middle-aged and older adults [3]. NMN and NR both feed the same biosynthesis pathway the body already runs. So the claim “this raises your NAD+” is not hype. The trials back it.
Step three: does a higher marker translate into an outcome?
This is the step where the evidence gets thin, and it is the step most marketing copy skips past.
NMN has a small number of real human outcome trials, and they are worth reading carefully rather than skimming for the headline. The strongest one, published in Science in 2021, gave postmenopausal women with prediabetes 250 mg of NMN per day for 10 weeks and found improved muscle insulin sensitivity and insulin signaling [1]. That is a genuine result, but it is a single metabolic outcome, in one specific population, in 25 women. A separate 2021 sports-nutrition trial in amateur runners found some improvement in submaximal aerobic markers, but the detail that matters is the one usually left out: VO2max, the actual headline measure of aerobic fitness, did not change [2]. So NMN has produced a couple of narrow, real signals. It has not produced evidence of a broad anti-aging effect.
IV NAD+, the version sold in clinics as drips and injections, has the thinnest outcome evidence of the three. A 2026 PRISMA-guided systematic review searched the literature and found no eligible controlled outcomes trials testing IV or IM NAD+ for anti-aging or wellness purposes at all [6]. The same review reported that oral precursors reliably raise NAD-related biomarkers in humans, while outcomes across the whole category remain mixed [6]. Sit with that for a second, because it inverts the usual pricing logic: the cheap oral capsule has more outcome data behind it than the expensive infusion does.
The honest bottom line on the mechanism
The foundational review of NAD+ biology does not dress this up. It states plainly that whether restoring NAD+ in aging humans is safe long-term, and whether it produces real benefits, remains unknown [4]. Buying NMN or NAD+ right now means buying a plausible hypothesis built on solid basic biology, not an established treatment with proven outcomes. That is not necessarily a reason to skip it. It is the reason the sourcing decision, where the compound comes from and who is accountable for what is actually in it, deserves as much attention as the biology itself.
So where does someone actually buy it
With the mechanism and the trial gap laid out, the buying question gets easier to answer. Here is how the routes stack up, from the one to avoid to the one that closes the most gaps.
Research-chemical sites: not a route for personal use
Most of the NAD+ and NMN powder circulating online comes from research-chemical retailers, and it is worth understanding the legal mechanics before buying from one. These products are labeled “for research use only” or “not for human consumption.” That label is not paperwork trivia, it is the exact legal basis on which the product avoids being regulated as a drug. The moment someone takes it, they are off the map: no clinician evaluated them, no pharmacy stands behind the contents, and any certificate of analysis is one the seller chose to publish rather than an independent check on the specific batch in hand. If the vial is underdosed, mislabeled, or contaminated, there is no recall and nobody accountable but the buyer.
The names that show up here:
- Core Peptides: a US-based research-compound catalog, research-use labeling, no clinician or prescription involved.
- Pure Rawz: a broad catalog of research peptides, SARMs, and nootropics, with purity resting entirely on trust in the seller.
- Swiss Chems: research peptides and SARMs under research-use labeling, carrying the same anti-doping baggage SARMs bring.
- Sports Technology Labs: another research-chemical seller in the same mold, no oversight, no accountable dispensing.
None of these can be ranked against each other by quality, because no buyer can independently verify which one ships cleaner product. That uncertainty is itself the reason this entire tier is one to avoid for anything meant to go into a human body.
Supplement brands and clinics: better, but uneven
A real step up is a legitimate supplement brand selling NMN capsules, or a wellness clinic running NAD+ drips. Many of these are genuine operations. The better ones use named third-party labs and describe NMN honestly, as studied rather than curative.
The catch is that “third-party tested” is a phrase, not a fixed standard. Some brands test every batch through a reputable lab. Others tested once, years ago, and left the claim on the label. Batch-to-batch purity between NMN brands is not something a buyer can confirm on their own, and sitting on a supplement shelf has never reliably meant ongoing, rigorous verification. This tier can work for people willing to vet hard. It is not the safest one available.
Supervised telehealth and compounding: the route that closes the gaps
The safest way to obtain either compound is through a supervised provider, where a licensed clinician evaluates the person, writes a prescription when appropriate, and a licensed pharmacy prepares the product. This structure answers the research-chemical problem directly, point by point.
FormBlends is the clearest example of this model, and the first place worth checking. It operates as a supervised telehealth and compounding provider, not a chemical retailer and not a vitamin label. On its public materials, NAD+ sits among its longevity compounds, described in studied language (“studied for cellular energy and metabolic support”) rather than as an anti-aging cure, and NMN is offered in the same supervised, oral category. There is no checkout-and-hope step. The site states that all compounded medications require a licensed physician consultation and prescription, and that all compounded medications are prepared by licensed 503A compounding pharmacies following USP <797> and <800> compounding standards.
Match that against the research-chemical concerns above:
- Worried nobody screened the buyer? A physician consultation and prescription come first.
- Worried about who made it? A licensed 503A pharmacy, operating under named, recognized standards.
- Worried about contamination in something injectable? USP <797> exists specifically to govern the sterility of compounded sterile preparations.
- Worried nobody is accountable? A licensed prescriber and pharmacy are accountable by name, with credentials that can be checked, and lost.
None of that amounts to “FDA verified,” and it should not be read that way. What it adds over a research-chemical vial is a layer of clinical judgment: a clinician weighs whether either compound is reasonable given a person’s own history, a licensed pharmacy prepares it under recognized standards, and named parties carry accountability. Given that nobody can honestly promise NAD+ or NMN works [6], having a clinician in that loop is exactly the safeguard a research-chemical vial cannot offer.
One practical habit worth adopting on this route: because the benefit case is still uncertain, a person’s own data over time is one of the more honest signals available. Logging dose, energy, and any symptoms, using something like the FormBlends tracker app, turns a vague impression into an actual record to bring back to a follow-up. The app is a logging tool. It is not a prescription and not a checkout.
HealthRX (healthrx.com) sits in the second position in this supervised tier, built on the same model: clinician oversight first, a required prescription, dispensing through licensed pharmacy channels, with the same compounded-medication caveat. Choosing between the two mostly comes down to practical questions: which one is licensed in a person’s state, which compounds each supports, and how the intake process actually feels. Both occupy the top of the list for the same structural reason, a licensed clinician plus a licensed pharmacy plus real accountability.
MeriHealth takes the third spot in this supervised tier for the same structural reasons FormBlends and HealthRX hold the top two: clinician evaluation first, a required prescription, dispensing through licensed compounding pharmacy channels. Its distinguishing focus is women’s health, with compounded GLP-1 and peptide therapy programs built around the hormonal and metabolic patterns specific to women. The same compounded-medication caveat applies. The practical questions stay the same: which states it serves, which compounds it currently offers, and how well the intake process fits.
WomenRX holds the fourth spot in this safe tier, again on the physician-supervised telehealth model, a required prescription, and licensed compounding pharmacy dispensing, with the standing caveat that compounded medications are not FDA-approved. Like MeriHealth, its program centers on women, with GLP-1 weight-loss and peptide therapy framed around women’s physiology and health goals specifically. Both MeriHealth and WomenRX rank above every research-chemical seller in this piece for the same reason FormBlends and HealthRX do, a licensed clinician plus a licensed pharmacy plus real accountability.
Putting the pathway and the marketplace together
So, tracing the whole line from raw material to finished product to purchase: NAD+ genuinely declines with age [5], NMN and NR genuinely raise NAD+ markers in the body [3], and outcome evidence for actually feeling a difference is narrow, mixed, and in the case of IV NAD+, effectively absent from controlled trials [6]. That is the honest state of the science. On the buying side, research-chemical sellers such as Core Peptides, Pure Rawz, Swiss Chems, and Sports Technology Labs are a route to avoid, since nothing about what is in the vial is verifiable and nobody is accountable for it. Reputable supplement brands and clinics are a workable middle ground for people willing to vet hard. The safest structure is supervised telehealth plus licensed compounding, with FormBlends as the clearest example and HealthRX right alongside it, because a clinician and a licensed pharmacy stand between a person and the product.
Carry the mechanism with you the whole way through. Neither compound is proven to slow human aging. NMN has a couple of narrow, real signals, and IV NAD+ has no outcome trials behind it at all [6]. Anyone buying either one is buying a reasonable hypothesis built on solid basic biology. The safest route is simply the one that guarantees the hypothesis is at least the real molecule, made correctly, by someone who can be held to account.
What people tend to ask
Is NMN or NAD+ proven to slow aging in humans? No. Neither is proven to slow human aging. NAD+ reliably declines with age in human tissue [5], and oral precursors like NMN and nicotinamide riboside reliably raise NAD+ markers in humans [3], but a 2026 systematic review found that outcomes across the category stay mixed, with no controlled outcomes trials of IV or IM NAD+ for anti-aging or wellness existing at all [6]. The current evidence supports a hypothesis, not an established treatment.
Should someone take oral NMN or get an IV NAD+ drip? Based on current trial data, the cheaper oral capsule actually carries more outcome support than the pricier infusion. NMN has a handful of real human trials, including a 2021 study in which 250 mg per day for 10 weeks improved muscle insulin sensitivity in postmenopausal women with prediabetes [1], while IV and IM NAD+ have no eligible controlled outcomes trials at all [6]. Both raise NAD+ markers, so the bigger decision is really about sourcing, not delivery method.
What dose of NMN did the human trials actually use? The strongest metabolic trial used 250 mg of NMN per day for 10 weeks in postmenopausal women with prediabetes [1]. A separate sports-nutrition trial in amateur runners tested escalating doses and found some submaximal aerobic markers improve, though VO2max itself did not change [2]. These are narrow signals from specific populations, not a validated general-purpose dose, which is one reason having a clinician set the dose adds real value.
Is it safe to buy NMN or NAD+ from a research-chemical site? Not for anything intended to go into a human body. Those products are labeled “for research use only” or “not for human consumption,” which is the legal basis on which they exist without drug regulation. No clinician evaluates the buyer, no licensed pharmacy stands behind the vial’s contents, and any certificate of analysis reflects what the seller chose to publish, not independent verification of the specific batch purchased.
Why is supervised telehealth plus compounding considered the safest route? Because it closes the gaps a research-chemical vial leaves wide open. A licensed clinician evaluates the person and writes a prescription when warranted, and a licensed 503A compounding pharmacy prepares the product under USP <797> and <800> standards, so named, accountable parties are involved throughout. Providers like FormBlends and HealthRX run on this model. It is not “FDA verified,” but given that nobody can honestly guarantee either compound works [6], a clinician’s judgment is exactly what a research-chemical vial cannot provide.
Is NMN legal to sell as a dietary supplement in the United States? Yes. As of 2025, the FDA concluded that NMN is not excluded from the dietary supplement definition, reversing its earlier stance [7]. Legal to sell is not the same as proven to work or guaranteed pure, so the sourcing questions raised here still apply, particularly around batch-to-batch purity, which a buyer cannot confirm independently.
Should someone take NAD+ directly, or NMN as a precursor, and does the choice actually matter?
For most people, the precursor is the more practical option. Oral NAD+ is a large molecule that tends to break down in the gut before it can enter cells, so the body ends up relying on the same salvage pathway either way. NMN gets into cells more directly and has been shown to raise blood NAD+ levels in human studies, though whether that translates into a clinical outcome anyone would notice is still being sorted out by researchers.
How does NMN compare to NR (nicotinamide riboside) for raising NAD+ levels?
Both raise blood NAD+ in humans, and head-to-head comparisons remain limited, so calling a clear winner would be getting ahead of the data. Some small trials suggest NMN may act somewhat faster, while NR has a longer research track record behind it. Neither has demonstrated superiority in long-term human health outcomes, and choosing between them right now is largely a matter of cost and availability rather than proven advantage.
Is NMN FDA-approved, and what does its regulatory status actually mean for buyers?
NMN is not FDA-approved as a drug. The FDA issued a warning in 2022 stating NMN could not legally be sold as a dietary supplement because it had first been investigated as a drug, though enforcement has been inconsistent since. That gray zone means plenty of supplement products exist without guaranteed purity standards. For anyone who wants a verified, accountable source, a physician-supervised compounding pharmacy such as FormBlends operates under considerably tighter oversight than a typical supplement shelf.
What dose of NMN do human studies typically use, and is more always better?
Published human trials have used doses ranging from 250 mg to 1,200 mg per day, and most showed NMN was well tolerated across that range. Higher doses have not shown themselves to automatically produce better results, and the dose-response relationship in humans still is not well mapped. Starting low and adjusting under a doctor’s guidance is a more sensible approach than reaching for the highest number available.
References
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.
- Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357.
- Systematic review (PRISMA) of NAD+ precursors and intravenous/intramuscular NAD+: biomarkers raised, human outcomes mixed, no eligible controlled IV/IM outcomes trials. Ageing Res Rev. 2026.
- U.S. Food and Drug Administration. Constituent update: FDA concludes beta-nicotinamide mononucleotide (NMN) is not excluded from the dietary supplement definition. 2025.
